Back to Index
Kiran K. Dhanireddy, MD
Assistant Professor of Clinical Surgery
Director of Transplant Quality
HCC 514 Health Sciences Campus Los Angeles
+1 323 442 5908


Dr. Dhanireddy is trained in surgical management of benign and malignant diseases of the pancreas and liver. He has a particular interest in liver resection and transplantation for the management of hepatocellular cancer. Additionally, he specializes in liver, kidney and pancreas transplantation.

Dr. Dhanireddy’s primary research interest is in transplant immune tolerance. He has written and co-authored multiple scientific manuscripts in this field. Additionally, Dr. Dhanireddy has published numerous book chapters and review articles on various topics, such as liver, kidney and pancreas transplant immunobiology. He is an active member of the American Society of Transplantation, the International Liver Transplant Society and the American Society of Transplant Surgeons.


Sheth M, Kulkarni S, Dhanireddy K, Perez A, Selby R. Blood Conservation Strategies and Liver Transplantation Transfusion-Free Techniques Derived from Jehovah's Witness Surgical Cohorts. Mo Med. 2015 Sep-Oct; 112(5):389-92. View in: PubMed

Lee C, Kim A, Santos I, Cen Y, Alexopoulos S, Navarro S, Wallman M, Dhanireddy K, Grant E. Cardiophrenic lymph nodes in liver transplant candidates with hepatocellular carcinoma: imaging characteristics and post-transplant outcomes. Clin Transplant. 2014 Dec; 28(12):1402-9. View in: PubMed

Boys JA, Doorly MG, Zehetner J, Dhanireddy KK, Senagore AJ. Can ultrasound common bile duct diameter predict common bile duct stones in the setting of acute cholecystitis? Am J Surg. 2014 Mar; 207(3):432-5. View in: PubMed

Alexopoulos S, Matsuoka L, Cho Y, Thomas E, Sheikh M, Stapfer M, Dhanireddy K, Sher L, Selby R, Genyk Y. Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher. Transplantation. 2013 Feb 15; 95(3):507-12. View in: PubMed

Derek E, Dhanireddy K. Immunosuppression. Curr Opin Organ Transplant. 2012 Dec; 17(6):616-8. View in: PubMed

Dhanireddy KK. Pancreas transplantation. Gastroenterol Clin North Am. 2012 Mar; 41(1):133-42. View in: PubMed

Dhanireddy KK, Bruno DA, Weaver TA, Xu H, Zhang X, Leopardi FV, Hale DA, Kirk AD. Portal venous donor-specific transfusion in conjunction with sirolimus prolongs renal allograft survival in nonhuman primates. Am J Transplant. 2009 Jan; 9(1):124-31. View in: PubMed

Xu H, Dhanireddy KK, Kirk AD. Human monocytes as intermediaries between allogeneic endothelial cells and allospecific T cells: a role for direct scavenger receptor-mediated endothelial membrane uptake in the initiation of alloimmunity. J Immunol. 2006 Jan 15; 176(2):750-61. View in: PubMed

Bruno DA, Dhanireddy KK, Kirk AD. Challenges in therapeutic strategies for transplantation: where now from here? Transpl Immunol. 2005 Dec; 15(2):149-55. View in: PubMed

Hale DA, Dhanireddy K, Bruno D, Kirk AD. Induction of transplantation tolerance in non-human primate preclinical models. Philos Trans R Soc Lond B Biol Sci. 2005 Sep 29; 360(1461):1723-37. View in: PubMed

Dhanireddy KK, Maniscalco J, Kirk AD. Is tolerance induction the answer to adolescent non-adherence? Pediatr Transplant. 2005 Jun; 9(3):357-63. View in: PubMed

Preston EH, Xu H, Dhanireddy KK, Pearl JP, Leopardi FV, Starost MF, Hale DA, Kirk AD. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am J Transplant. 2005 May; 5(5):1032-41. View in: PubMed

Dhanireddy KK, Xu H, Mannon RB, Hale DA, Kirk AD. The clinical application of monoclonal antibody therapies in renal transplantation. Expert Opin Emerg Drugs. 2004 May; 9(1):23-37. View in: PubMed

Powered bySC CTSI